|
C10ORF12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.118630E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.395000E-01 |
| Normal-vs-Stage2 |
4.042500E-02 |
| Normal-vs-Stage3 |
7.822500E-03 |
| Normal-vs-Stage4 |
2.796400E-01 |
| Stage1-vs-Stage2 |
1.989360E-01 |
| Stage1-vs-Stage3 |
2.527800E-02 |
| Stage1-vs-Stage4 |
6.942000E-01 |
| Stage2-vs-Stage3 |
8.542400E-01 |
| Stage2-vs-Stage4 |
4.731000E-01 |
| Stage3-vs-Stage4 |
3.349400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.354570E-01 |
| Normal-vs-AfricanAmerican |
5.632400E-01 |
| Normal-vs-Asian |
7.258000E-02 |
| Caucasian-vs-AfricanAmerican |
7.323700E-02 |
| Caucasian-vs-Asian |
4.523600E-01 |
| AfricanAmerican-vs-Asian |
6.643700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.052070E-02 |
| Normal-vs-Female |
2.421800E-01 |
| Male-vs-Female |
4.812300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.324800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.056100E-02 |
| Normal-vs-Age(61-80Yrs) |
5.945500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.667400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.258400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.299600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.375400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.619600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.229800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.991200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.260400E-03 |
| Classical-VS-Follicular |
1.458400E-03 |
| Classical-VS-Other |
2.007000E-01 |
| Classical-VS-Normal |
5.577800E-01 |
| Tall-VS-Follicular |
9.867000E-01 |
| Tall-VS-Other |
7.473800E-01 |
| Tall-VS-Normal |
1.082400E-02 |
| Follicular-VS-Other |
7.832600E-01 |
| Follicular-VS-Normal |
2.580200E-03 |
| Other-VS-Normal |
9.152000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.091920E-02 |
| Normal-vs-N1 |
1.241780E-01 |
| N0-vs-N1 |
7.059600E-01 |
|
|
